Table 2. Comparison of the survival distributions of patients sub-grouped based on miRNA expression.
Survival analysis: PFS for patients with low vs high miRNA expressing tumors | |||
---|---|---|---|
miRNA | p-value Log-rank test | adjusted p-value Log-rank test | |
1 | miR-16 | 0.095 | 0.249 |
2 | miR-18a | 0.524 | 0.576 |
3 | miR-19b | 0.468 | 0.544 |
4 | miR-21 | 0.329 | 0.483 |
5 | miR-26b | 0.995 | 0.995 |
6 | miR-31 | 0.276 | 0.433 |
7 | miR-34a | 0.196 | 0.376 |
8 | miR-92a | 0.040 | 0.219 |
9 | miR-93 | 0.023 | 0.168 |
10 | miR-103 | 0.160 | 0.351 |
11 | miR-125b | 0.055 | 0.219 |
12 | miR-137 | 0.060 | 0.219 |
13 | miR-140 | 0.856 | 0.897 |
14 | miR-143 | 0.001 | 0.012 |
15 | miR-145 | 0.100 | 0.249 |
16 | miR-148a | 0.390 | 0.536 |
17 | miR-191 | 0.205 | 0.376 |
18 | miR-192 | 0.102 | 0.249 |
19 | miR-215 | 0.009 | 0.095 |
20 | miR-222 | 0.470 | 0.544 |
21 | miR-let7a | 0.464 | 0.544 |
22 | miR-let7g | 0.244 | 0.413 |